Terms: = Endocrine gland cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS
269 results:
1. Exosomal HSPB1, interacting with fus protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450.
Zhang L; Yang L; Du K
J Cell Mol Med; 2024 May; 28(9):e18209. PubMed ID: 38682349
[TBL] [Abstract] [Full Text] [Related]
2. Neil 1 deficiency facilitates chemoresistance through upregulation of RAD18 expression in ovarian cancer stem cells.
Shukla D; Mandal T; Srivastava AK
Biochem Biophys Res Commun; 2024 Jun; 712-713():149907. PubMed ID: 38636303
[TBL] [Abstract] [Full Text] [Related]
3. Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma.
Xu AM; Haro M; Walts AE; Hu Y; John J; Karlan BY; Merchant A; Orsulic S
Sci Adv; 2024 Apr; 10(16):eadk8805. PubMed ID: 38630822
[TBL] [Abstract] [Full Text] [Related]
4. Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma.
Rupp L; Dietsche I; Kießler M; Sommer U; Muckenhuber A; Steiger K; van Eijck CWF; Richter L; Istvanffy R; Jäger C; Friess H; van Eijck CHJ; Demir IE; Reyes CM; Schmitz M
Front Immunol; 2024; 15():1378190. PubMed ID: 38629072
[TBL] [Abstract] [Full Text] [Related]
5. Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model.
Kim S; Lee JY; Park EJ; Ahn YD; Cheon Y; Sim W; Lee HJ
Eur Radiol Exp; 2024 Mar; 8(1):39. PubMed ID: 38503996
[TBL] [Abstract] [Full Text] [Related]
6. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer.
Han PZ; Ye WD; Yu PC; Tan LC; Shi X; Chen XF; He C; Hu JQ; Wei WJ; Lu ZW; Qu N; Wang Y; Ji QH; Ji DM; Wang YL
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38478516
[TBL] [Abstract] [Full Text] [Related]
7. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
8. Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma.
Gao Z; Azar J; Zhu H; Williams-Perez S; Kang SW; Marginean C; Rubinstein MP; Makawita S; Lee HS; Camp ER
Front Immunol; 2024; 15():1324093. PubMed ID: 38361928
[TBL] [Abstract] [Full Text] [Related]
9. Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation.
Liu X; Liu H; Wang L; Han Y; Kong L; Zhang X
Diagn Pathol; 2024 Feb; 19(1):29. PubMed ID: 38341587
[TBL] [Abstract] [Full Text] [Related]
10. Profiling of Unfolded Protein Response Markers and Effect of IRE1α-specific Inhibitor in Pituitary Neuroendocrine Tumor.
Morita S; Uraki S; Ariyasu H; Tsuji T; Doi A; Furuta H; Yamoto T; Nakao N; Akamizu T; Matsuoka TA
Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38289718
[TBL] [Abstract] [Full Text] [Related]
11. LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-fus-FSP1 complex.
Wang S; Chen J; Li P; Chen Y
Cell Death Dis; 2023 Nov; 14(11):767. PubMed ID: 38007473
[TBL] [Abstract] [Full Text] [Related]
12. Apoptotic Effect of Gallic Acid via Regulation of p-p38 and ER Stress in PANC-1 and MIA PaCa-2 Cells Pancreatic cancer Cells.
Kim JW; Choi J; Park MN; Kim B
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894916
[TBL] [Abstract] [Full Text] [Related]
13. Tyrosine catabolism enhances genotoxic chemotherapy by suppressing translesion DNA synthesis in epithelial ovarian cancer.
Li J; Zheng C; Mai Q; Huang X; Pan W; Lu J; Chen Z; Zhang S; Zhang C; Huang H; Chen Y; Guo H; Wu Z; Deng C; Jiang Y; Li B; Liu J; Yao S; Pan C
Cell Metab; 2023 Nov; 35(11):2044-2059.e8. PubMed ID: 37890478
[TBL] [Abstract] [Full Text] [Related]
14. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
Karatug Kacar A
Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
[TBL] [Abstract] [Full Text] [Related]
15. Expression of GRP78 and its copartners in HEK293 and pancreatic cancer cell lines (BxPC-3/PANC-1) exposed to MRI and CT contrast agents.
Azzawri AA; Yildirim IH; Yegin Z; Dusak A
Nucleosides Nucleotides Nucleic Acids; 2024; 43(5):391-416. PubMed ID: 37787049
[TBL] [Abstract] [Full Text] [Related]
16. Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound.
Spiers L; Gray M; Lyon P; Sivakumar S; Bekkali N; Scott S; Collins L; Carlisle R; Wu F; Middleton M; Coussios C
BMC Cancer; 2023 Sep; 23(1):896. PubMed ID: 37741968
[TBL] [Abstract] [Full Text] [Related]
17. [Diffuse large B-cell lymphoma of thyroid invading the superior mediastinum with hashimoto's thyroiditis: a case report and literature review].
Lv J; Yu T; Yin W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 37(9):755-758. PubMed ID: 37640999
[No Abstract] [Full Text] [Related]
18. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
[TBL] [Abstract] [Full Text] [Related]
19. Pancreatic follicular dendritic cell sarcoma: a rare case report and systematic literature review of 7 cases.
Li X; Gu J; He Q; Han S; Wu H
World J Surg Oncol; 2023 Jul; 21(1):212. PubMed ID: 37480085
[TBL] [Abstract] [Full Text] [Related]
20. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance.
Zou X; Lin X; Cheng H; Chen Y; Wang R; Ma M; Liu Y; Dai Z; Tasiheng Y; Yan Y; Hou Q; Ding F; Chen H; Yu X; Wang X; Liu C
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364934
[TBL] [Abstract] [Full Text] [Related]
[Next]
